One hundred units equals 1 milliliter

Reported complications described in some GLP-1 drug claims have included: Severe or persistent gastrointestinal symptoms , such as ongoing nausea, vomiting, or abdominal pain Delayed stomach emptying (gastroparesis) , which has been described by some individuals as involving bloating, nausea, vomiting, or difficulty tolerating food Intestinal complications , including reduced bowel activity (ileus), which may involve abdominal discomfort, cramping, or vomiting Gallbladder-related conditions , such as gallstones or gallbladder inflammation Blood-clot-related conditions , including deep vein thrombosis or pulmonary embolism, described in some reports and legal filings Vision-related problems , including reports involving non-arteritic anterior ischemic optic neuropathy (NAION) discussed in connection with semaglutide in certain contexts Not everyone who takes a GLP-1 medication experiences these issues, and the relationship between GLP-1 drugs and reported complications continues to be evaluated in legal proceedings

In addition, data of a unique long-acting triagonist were recently presented in preclinical DIO mice models of T2DM
Li, Y., Huang, M., Wang, M., Wang, Y., Deng, P., Li, C., Huang, J., Chen, H., Wei, Z., Ouyang, Q., Zhao, J., Lu, Y., & Su, S
No dosing has FDA approval for adult longevity or body composition use
However, if this is not covered under your plan, Zepbound can be bought for $650 for a 30 day supply